References
1. Allali S, Montalembert MD, Brousse V, et al. Hepatobiliary
complications in children with sickle cell disease: a retrospective
review of medical records from 616 patients. J Clin Med .
2019;8(9):1481-1481. doi:10.3390/jcm8091481.
2. Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary
manifestations of sickle cell disease: a review. World J
Gastrointest Pathophysiol . 2017;8(3):108-116.
doi:10.4291/wjgp.v8.i3.108.
3. Ahn H, Li C, Wang W. Sickle cell hepatopathy: clinical presentation,
treatment, and outcome in pediatric and adult patients. Pediatr
Blood Cancer . 2005;45(2):184-190. doi:10.1002/pbc.20317.
4. Pecker LH, Patel N, Creary S, et al. Diverse manifestations of acute
sickle cell hepatopathy in pediatric patients with sickle cell disease:
a case series. Pediatr Blood Cancer . 2018;65(8):e27060.
doi:10.1002/pbc.27060.
5.Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy.Hepatology. 2001;33(5):1021-1028. doi:10.1053/jhep.2001.24114.
6. Buchanan GR, Glader BE. Benign course of extreme hyperbilirubinemia
in sickle cell anemia: analysis of six cases. J Pediatr . Jul
1977;91(1):21-4. doi:10.1016/s0022-3476(77)80436-8.
7. Gardner K, Suddle A, Kane P, et al. How we treat sickle hepatopathy
and liver transplantation in adults. Blood .
2014;123(15):2302-2307. doi:10.1182/blood-2013-12-542076.
8. Ahmed N, Chizhevsky V. Acute hepatic sequestration associated with
pneumococcal infection in a 5-year-old boy with sickle
β0-thalassemia: a case report and review of the
literature. J Pediatr Hematol Oncol . 2007;29(10):720-724.
doi:10.1097/MPH.0b013e31814d6866.
9.Tsunoda T, Inui A, Iwasawa K, et al. Acute liver dysfunction not
resulting from hepatitis virus in immunocompetent children.Pediatr Int . 2017;59(5):551-556. doi:10.1111/ped.13249.
10. Lee ES, Chu PC. Reverse sequestration in a case of sickle crisis.Postgrad Med J . Aug 1996;72(850):487-8.
doi:10.1136/pgmj.72.850.487.
11. Leonardsson H, Löve A, Björnsson ES, Hreinsson JP. Hepatitis due to
Epstein–Barr virus and cytomegalovirus: clinical features and
outcomes.. Scand J Gastroenterol . 2017;52(8):893-897.
doi:10.1080/00365521.2017.1319972.
12. Crum NF. Epstein Barr virus hepatitis: case series and review.South Med J. 2006;99(5):544-548.
13. Drebber U, Kasper HU, Krupacz J, et al. The role of Epstein–Barr
virus in acute and chronic hepatitis. J Hepatol .
2006;44(5):879-885. doi:10.1016/j.jhep.2006.02.006.
14. Massei F, Palla G, Ughi C, Macchia P, Maggiore G. Cholestasis as a
presenting feature of acute Epstein-Barr virus infection. Pediatr
Infect Dis J . 2001;20(7):721-722. doi:10.1097/00006454-200107000-00020.
15. Bernstein CN, Minuk GY. Infectious mononucleosis presenting with
cholestatic liver disease. Ann Intern Med . 1998;128(6):509.
16. Barlow G, Kilding R, Green ST. Epstein-Barr virus infection
mimicking extrahepatic biliary obstruction. J R Soc Med .
2000;93(6):316-318. doi:10.1177/014107680009300612.
17. Kang MJ, Kim TH, Shim KN, et al. Infectious mononucleosis hepatitis
in young adults: two case reports. Korean J Intern Med .
2009;24(4):381-387. doi:10.3904/kjim.2009.24.4.381.
18. Edoute Y, Lachter J, Furman E, Baruch Y, Assy N, Bassan L. Case
report: severe cholestatic jaundice induced by Epstein-Barr virus
infection in the elderly. JGH Open. 1998;13(8):821-824.
doi:10.1111/j.1440-1746.1998.tb00739.x.
19.Canović P, Gajović O, Todorović Z, Mijailović Z. Epstein-Barr virus
hepatitis associated with icterus - a case report. Med Pregl .
2006;59(3-4):179-182. doi:10.2298/MPNS0604179C.
20. Pagidipati N, Obstein KL, Rucker-Schmidt R, Odze RD, Thompson CC.
Acute hepatitis due to Epstein–Barr virus in an immunocompetent
patient. Dig Dis Sci. 2010;55:1182-1185.
doi:10.1007/s10620-009-0835-z.
21.Black TP, Rao A. Epstein Barr virus induced cholestatic hepatitis in
a patient with hemoglobin SC disease. American Journal of Case
Reports . 2011;12:58-61. doi:10.12659/AJCR.881780.
TABLE 1. Spectrum of acute sickle cell hepatopathy in childhood
1Adapted from Shah et al. , Banerjee et
al., and Buchanan & Glader. Abbreviations: ALT, alanine transaminase;
AST, aspartate transaminase; RUQ, right upper quadrant.
FIGURE 1. Laboratory values versus time since hospital admission for two
patients with EBV-induced sickle hepatopathy. Abbreviations: ALT, serum
alanine transaminase; CR, serum creatinine; CRRT, continuous renal
replacement therapy; Hb, hemoglobin; PLT, platelet count; T. BILI, serum
total bilirubin; Txn, transfusion (erythrocytes).